Vor Biopharma Inc.
VOR- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001817229
No open-market purchases or sales by Vor Biopharma Inc. insiders were filed in the last 90 days; 155 institutions reported holding it in 13F filings for Q3 2026, worth $1.06B in total; no superinvestor holds it.
13F holders, Q3 2026
Institutional positions in Vor Biopharma Inc. as of Sep 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 155
- +55 vs. Q2 2026
- Shares held
- 55.3M
- +6.80M (+14.0%) vs. Q2 2026
- Total value
- $1.06B
- +$162.6M (+18.2%) vs. Q2 2026
- New holders
- 67
- 41 more added
- Sold out
- 12
- 37 more reduced
2 institutions that held it in Q2 2026 haven't filed for Q3 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VOR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q3 2026 | 155 | $1.06B |
| Q2 2026 | 102 | $893.0M |
| Q1 2026 | 80 | $716.9M |
| Q4 2025 | 55 | $332.0M |
| Q3 2025 | 37 | $183.4M |
| Q2 2025 | 35 | $91.9M |
| Q1 2025 | 46 | $43.2M |
| Q4 2024 | 52 | $67.6M |
| Q3 2024 | 54 | $33.5M |
| Q2 2024 | 71 | $54.5M |
| Q1 2024 | 69 | $139.7M |
| Q4 2023 | 60 | $134.1M |
| Q3 2023 | 59 | $127.7M |
| Q2 2023 | 71 | $187.8M |
| Q1 2023 | 60 | $325.7M |
| Q4 2022 | 58 | $400.3M |
| Q3 2022 | 48 | $125.5M |
| Q2 2022 | 49 | $154.8M |
| Q1 2022 | 58 | $187.9M |
| Q4 2021 | 61 | $362.0M |
| Q3 2021 | 55 | $481.2M |
| Q2 2021 | 51 | $571.2M |
| Q1 2021 | 49 | $1.31B |
Institutions, Q3 2026
Shares, value and share of portfolio for each institution holding Vor Biopharma Inc.; share changes are against Q2 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| FMR LLC | 6,759,007 | $129.0M | 0.01% | +1,826,858+37.0% | Added |
| TCG Crossover Management, LLC | 5,673,078 | $108.2M | 3.06% | 00.0% | Unchanged |
| Ra Capital Management, L.P. | 4,503,882 | $85.9M | 0.86% | +2,101,787+87.5% | Added |
| FCPM III Services B.V. | 3,405,279 | $65.0M | 6.13% | −712,075−17.3% | Reduced |
| BlackRock, Inc. | 3,306,494 | $63.1M | 0.00% | −161,613−4.7% | Reduced |
| VR Adviser, LLC | 3,041,719 | $58.0M | 2.82% | 00.0% | Unchanged |
| Frazier Life Sciences Management, L.P. | 2,743,939 | $52.4M | 1.30% | +200,000+7.9% | Added |
| Vanguard Capital Management LLC | 2,035,477 | $38.8M | 0.00% | −48,851−2.3% | Reduced |
| State Street Corp | 1,969,801 | $37.6M | 0.00% | −646,535−24.7% | Reduced |
| Caligan Partners LP | 1,925,066 | $36.7M | 2.25% | 00.0% | Unchanged |
| Great Point Partners LLC | 1,126,910 | $21.5M | 5.64% | −573,090−33.7% | Reduced |
| Millennium Management LLC | 991,532 | $18.9M | 0.01% | +563,465+131.6% | Added |
| Geode Capital Management, LLC | 979,890 | $18.7M | 0.00% | −82,579−7.8% | Reduced |
| Nantahala Capital Management, LLC | 931,644 | $17.8M | 1.00% | +86,644+10.3% | Added |
| Paradigm Biocapital Advisors LP | 889,575 | $17.0M | 0.34% | −860,425−49.2% | Reduced |
| Federated Hermes, Inc. | 760,221 | $14.5M | 0.02% | +760,221 | New |
| Goldman Sachs Group Inc | 746,214 | $14.2M | 0.00% | +417,322+126.9% | Added |
| Nan Fung Trinity (HK) Ltd | 721,550 | $13.8M | 1.32% | +75,000+11.6% | Added |
| Boothbay Fund Management, LLC | 646,521 | $12.3M | 0.27% | +87,819+15.7% | Added |
| NEXTBio Capital Management LP | 620,931 | $11.8M | 5.05% | −268,233−30.2% | Reduced |
| Rosalind Advisors, Inc. | 609,199 | $11.6M | 3.76% | −39,401−6.1% | Reduced |
| UBS Group AG | 583,666 | $11.1M | 0.00% | +90,388+18.3% | Added |
| Marshall Wace, LLP | 560,715 | $10.7M | 0.01% | +465,072+486.3% | Added |
| Vivo Capital, LLC | 550,358 | $10.5M | 1.16% | +550,358 | New |
| Ameriprise Financial Inc | 537,150 | $10.2M | 0.00% | +537,150 | New |
| ADAR1 Capital Management, LLC | 531,349 | $10.1M | 0.43% | −149,277−21.9% | Reduced |
| Citadel Advisors LLC | 497,989 | $9.50M | 0.01% | +337,575+210.4% | Added |
| Adage Capital Partners GP, L.L.C. | 490,000 | $9.35M | 0.01% | +490,000 | New |
| Franklin Resources Inc | 425,735 | $8.57M | 0.00% | +425,735 | New |
| Sphera Funds Management Ltd. | 383,417 | $7.32M | 1.11% | −33,000−7.9% | Reduced |
| Integral Health Asset Management, LLC | 350,000 | $6.68M | 0.41% | +350,000 | New |
| Point72 Asset Management, L.P. | 343,037 | $6.55M | 0.01% | +343,037 | New |
| Charles Schwab Investment Management Inc | 340,442 | $6.50M | 0.00% | +219,044+180.4% | Added |
| Vanguard Portfolio Management LLC | 333,308 | $6.36M | 0.00% | −7,056−2.1% | Reduced |
| Braidwell LP | 319,308 | $6.09M | 0.25% | −253,796−44.3% | Reduced |
| Northern Trust Corp | 308,867 | $5.89M | 0.00% | −19,875−6.0% | Reduced |
| Susquehanna International Group, LLP | 300,529 | $5.73M | 0.01% | +284,075+1,726.5% | Added |
| Vanguard Fiduciary Trust Co | 277,062 | $5.29M | 0.00% | −23,642−7.9% | Reduced |
| Eversept Partners, LP | 268,389 | $5.12M | 0.30% | +118,708+79.3% | Added |
| Ikarian Capital, LLC | 250,000 | $4.77M | 0.95% | +250,000 | New |
| D. E. Shaw & Co., Inc. | 243,226 | $4.64M | 0.00% | +188,555+344.9% | Added |
| StemPoint Capital LP | 200,836 | $3.83M | 0.69% | +200,836 | New |
| Woodline Partners LP | 194,242 | $3.71M | 0.01% | −185,481−48.8% | Reduced |
| AQR Capital Management LLC | 175,775 | $3.35M | 0.00% | +175,775 | New |
| Wellington Management Group LLP | 136,603 | $2.61M | 0.00% | +109,503+404.1% | Added |
| ExodusPoint Capital Management, LP | 131,545 | $2.51M | 0.02% | +131,545 | New |
| Axiom Investors LLC | 124,196 | $2.37M | 0.02% | +32,091+34.8% | Added |
| Bank of America Corp | 117,592 | $2.24M | 0.00% | −60,147−33.8% | Reduced |
| J. Goldman & Co LP | 108,793 | $2.08M | 0.07% | +108,793 | New |
| Morgan Stanley | 101,018 | $1.93M | 0.00% | +39,457+64.1% | Added |
| Bank of New York Mellon Corp | 97,557 | $1.86M | 0.00% | −165−0.2% | Reduced |
| Nuveen, LLC | 90,845 | $1.73M | 0.00% | −3,970−4.2% | Reduced |
| Alps Advisors Inc | 78,371 | $1.50M | 0.01% | +23,373+42.5% | Added |
| Invesco Ltd. | 73,277 | $1.40M | 0.00% | +4,976+7.3% | Added |
| XTX Topco Ltd | 71,910 | $1.37M | 0.02% | −10,735−13.0% | Reduced |
| Weiss Asset Management LP | 71,755 | $1.37M | 0.02% | +71,755 | New |
| Aquatic Capital Management LLC | 70,959 | $1.35M | 0.04% | +70,959 | New |
| Rhumbline Advisers | 56,994 | $1.09M | 0.00% | −534−0.9% | Reduced |
| Johnson & Johnson | 53,732 | $1.03M | 0.13% | 00.0% | Unchanged |
| Susquehanna Portfolio Strategies, LLC | 52,551 | $1.00M | 0.02% | +52,551 | New |
| STRS Ohio | 47,400 | $904.4K | 0.00% | +47,400 | New |
| Rafferty Asset Management, LLC | 47,382 | $904.0K | 0.00% | −1,436−2.9% | Reduced |
| Swiss National Bank | 43,800 | $835.7K | 0.00% | +43,800 | New |
| Price T Rowe Associates Inc | 40,097 | $766.0K | 0.00% | −1,718−4.1% | Reduced |
| Alliancebernstein L.P. | 37,210 | $710.0K | 0.00% | 00.0% | Unchanged |
| Deutsche Bank AG | 34,665 | $661.4K | 0.00% | −5,686−14.1% | Reduced |
| JPMorgan Chase & Co | 34,397 | $630.5K | 0.00% | +12,776+59.1% | Added |
| BNP Paribas Arbitrage, SA | 31,311 | $597.4K | 0.00% | +20,603+192.4% | Added |
| Acadian Asset Management LLC | 28,057 | $533.0K | 0.00% | +28,057 | New |
| Tudor Investment Corp Et Al | 27,468 | $524.1K | 0.00% | +7,848+40.0% | Added |
| SEI Investments Co | 26,267 | $501.2K | 0.00% | +3,248+14.1% | Added |
| California State Teachers Retirement System | 25,519 | $486.9K | 0.00% | +24,957+4,440.7% | Added |
| Sarissa Capital Management LP | 25,399 | $484.6K | 0.32% | 00.0% | Unchanged |
| Squarepoint Ops LLC | 24,925 | $475.6K | 0.00% | +1,694+7.3% | Added |
| MetLife Investment Management | 24,442 | $466.4K | 0.00% | 00.0% | Unchanged |
| Birchview Capital, LP | 24,000 | $457.9K | 0.26% | +24,000 | New |
| Citigroup Inc | 22,564 | $430.5K | 0.00% | −40,566−64.3% | Reduced |
| Virtus Investment Advisers, Inc. | 22,098 | $421.6K | 0.09% | −687−3.0% | Reduced |
| Mirae Asset Global ETFs Holdings Ltd. | 22,081 | $418.6K | 0.00% | −2,300−9.4% | Reduced |
| Gsa Capital Partners LLP | 19,248 | $367.0K | 0.02% | +19,248 | New |
| Optimize Financial Inc | 19,228 | $366.9K | 0.07% | +19,228 | New |
| Persistent Asset Partners Ltd | 18,939 | $361.4K | 0.11% | +18,939 | New |
| UBS Asset Management Americas Inc | 18,832 | $359.3K | 0.00% | +18,832 | New |
| Legal & General Group Plc | 18,242 | $348.1K | 0.00% | +10,231+127.7% | Added |
| Algert Global LLC | 18,110 | $345.5K | 0.00% | +18,110 | New |
| Manufacturers Life Insurance Company, The | 17,964 | $342.8K | 0.00% | +7,171+66.4% | Added |
| Barclays PLC | 17,541 | $334.7K | 0.00% | +2,976+20.4% | Added |
| Profund Advisors LLC | 16,811 | $320.8K | 0.01% | −7,780−31.6% | Reduced |
| Engineers Gate Manager LP | 16,780 | $320.2K | 0.00% | −20,171−54.6% | Reduced |
| Vanguard Asset Management, Ltd | 16,303 | $311.1K | 0.00% | +16,303 | New |
| Quantinno Capital Management LP | 16,084 | $306.9K | 0.00% | +16,084 | New |
| Vanguard Global Advisers, LLC | 14,843 | $283.2K | 0.00% | −3,104−17.3% | Reduced |
| New York State Common Retirement Fund | 14,300 | $272.8K | 0.00% | 00.0% | Unchanged |
| SummitTX Capital, L.P. | 13,786 | $263.0K | 0.01% | +13,786 | New |
| Wells Fargo & Company | 12,539 | $239.2K | 0.00% | −23,734−65.4% | Reduced |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 12,448 | $237.5K | 0.00% | +12,448 | New |
| Magnetar Financial LLC | 12,009 | $229.1K | 0.00% | +12,009 | New |
| Creative Planning | 11,586 | $221.1K | 0.00% | +11,586 | New |
| Shay Capital LLC | 11,000 | $209.9K | 0.03% | −2,695−19.7% | Reduced |
| Brevan Howard Capital Management LP | 10,813 | $206.3K | 0.00% | +10,813 | New |